Evidence presented in Table 1 shows that patients with T2D and coronary heart disease who received omega-3 fatty acids, at an average dose of 1000 mg twice a day for 3 months, had an improved metabolic profile, including decreasing insulin and hs-CRP concentrations, which were associated with enhancing plasma GSH levels [32]. This evidence concerns the gene INS and type 2 diabetes mellitus.